Medicine Description rinvoq 15mg
rinvoq 15mg tablets is a medication that primarily works by selectively inhibiting Janus kinase 1 (JAK1), which is crucial for the signaling pathways involved in the immune response and inflammation. By targeting JAK1, Upadacitinib disrupts the phosphorylation process of various cytokines and growth factors, leading to a reduction in inflammatory processes. This modulation of the immune system allows for a systematic improvement in conditions characterized by excessive inflammation and joint damage.
Indications and Uses of rinvoq 15mg tablets
- Rheumatoid arthritis in adult patients who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.
- Ulcerative colitis in adults who have had an inadequate response to conventional therapy.
- Atopic dermatitis in adults and pediatric patients aged 12 years and older.
Side Effects of rinvoq 15mg tablets
- Upper respiratory tract infections
- Nausea
- Headache
- Fatigue
- Increased liver enzymes
- Potential increased risk of serious infections
- Changes in blood lipid levels
Storage and Handling
Store rinvoq 15mg tablets at room temperature, away from moisture and heat. Ensure that the medication is kept out of reach of children.
Patient Advice and Precautions
Before starting treatment, patients should discuss their complete medical history with their healthcare provider, including any past infections or liver conditions. Monitoring for signs of infections and routine blood tests may be necessary during treatment. Patients should also be advised to report any unusual symptoms, such as fever or persistent fatigue, to their healthcare provider promptly.